Robert F Leeman1, Qisi Sun2, Devorah Bogart3, Cheryl L Beseler4, Mehmet Sofuoglu1. 1. a Psychiatry , Yale School of Medicine , New Haven , Connecticut , USA. 2. b Ecology and Evolutionary Biology, Yale University , New Haven , Connecticut , USA. 3. c Psychology, Yale University , New Haven , Connecticut , USA. 4. d Psychology, Colorado State University , Fort Collins , Colorado , USA.
Abstract
BACKGROUND: Cocaine and opioid co-use is a notable public health concern, but little is known about correlates of this behavior. Most prior findings come from treatment samples and concern cocaine and heroin. Findings from a nationally representative sample involving primarily prescription opioid misuse would expand knowledge. METHODS: Past-12-month cocaine and/or opioid users in Wave 1 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) formed the sample (N = 839). Cocaine-only, opioid-only, and cocaine/opioid co-users were compared regarding sociodemographics, other substance involvement, psychiatric, and medical conditions/events. RESULTS: Opioid-only users were the largest group (n = 622), followed by cocaine-only (n = 144) and co-users (n = 73). The vast majority of opioid misuse was of prescription opioids (1.4% with past-12-month use of heroin). Notably, co-users did not differ from single drug users in frequency of use of either drug. Co-users did not have significantly greater incidence of any psychiatric conditions, medial conditions, or events. In preliminary analyses, co-users were more likely than either single use group to report several classes of other drug use. However, for most comparisons, opioid use did not add substantial risk beyond cocaine use. Differences on multiple sociodemographic variables suggested opioid-only users were at lowest risk of negative outcomes. These results may relate to a finding that opioid-only users were less likely to have sought treatment. CONCLUSIONS/IMPORTANCE: This sample of past-12-month cocaine and/or opioid users had greater involvement with other substances, more psychiatric and medical conditions compared to the general population. Co-users had greater involvement with other substances than opioid-only users in particular.
BACKGROUND:Cocaine and opioid co-use is a notable public health concern, but little is known about correlates of this behavior. Most prior findings come from treatment samples and concern cocaine and heroin. Findings from a nationally representative sample involving primarily prescription opioid misuse would expand knowledge. METHODS: Past-12-month cocaine and/or opioid users in Wave 1 of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) formed the sample (N = 839). Cocaine-only, opioid-only, and cocaine/opioid co-users were compared regarding sociodemographics, other substance involvement, psychiatric, and medical conditions/events. RESULTS: Opioid-only users were the largest group (n = 622), followed by cocaine-only (n = 144) and co-users (n = 73). The vast majority of opioid misuse was of prescription opioids (1.4% with past-12-month use of heroin). Notably, co-users did not differ from single drug users in frequency of use of either drug. Co-users did not have significantly greater incidence of any psychiatric conditions, medial conditions, or events. In preliminary analyses, co-users were more likely than either single use group to report several classes of other drug use. However, for most comparisons, opioid use did not add substantial risk beyond cocaine use. Differences on multiple sociodemographic variables suggested opioid-only users were at lowest risk of negative outcomes. These results may relate to a finding that opioid-only users were less likely to have sought treatment. CONCLUSIONS/IMPORTANCE: This sample of past-12-month cocaine and/or opioid users had greater involvement with other substances, more psychiatric and medical conditions compared to the general population. Co-users had greater involvement with other substances than opioid-only users in particular.
Entities:
Keywords:
Cocaine; alcohol use disorder; cannabis; comorbidity; epidemiology; help-seeking; heroin; nicotine; opioid; poly-substance use
Authors: Fabian Termorshuizen; Anneke Krol; Maria Prins; Ronald Geskus; Wim van den Brink; Erik J C van Ameijden Journal: Drug Alcohol Depend Date: 2005-02-24 Impact factor: 4.492
Authors: Chinazo O Cunningham; Angela Giovanniello; Hillary V Kunins; Robert J Roose; Aaron D Fox; Nancy L Sohler Journal: Am J Addict Date: 2013 Jul-Aug
Authors: Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering Journal: Drug Alcohol Depend Date: 2003-07-20 Impact factor: 4.492
Authors: Ludwing Flórez-Salamanca; Roberto Secades-Villa; Deborah S Hasin; Linda Cottler; Shuai Wang; Bridget F Grant; Carlos Blanco Journal: Am J Drug Alcohol Abuse Date: 2013-05 Impact factor: 3.829
Authors: Eduardo R Butelman; Carina Y Chen; Kimberly J Lake; Kate G Brown; Mary Jeanne Kreek Journal: Exp Clin Psychopharmacol Date: 2020-10-29 Impact factor: 3.157
Authors: Brian Chan; Karli Kondo; Michele Freeman; Chelsea Ayers; Jessica Montgomery; Devan Kansagara Journal: J Gen Intern Med Date: 2019-06-10 Impact factor: 5.128
Authors: Jiayi Tong; Zhaoyi Chen; Rui Duan; Wei-Hsuan Lo-Ciganic; Tianchen Lyu; Cui Tao; Peter A Merkel; Henry R Kranzler; Jiang Bian; Yong Chen Journal: AMIA Annu Symp Proc Date: 2021-01-25
Authors: Eduardo R Butelman; Angelo G I Maremmani; Silvia Bacciardi; Carina Y Chen; Joel Correa da Rosa; Mary Jeanne Kreek Journal: Front Psychiatry Date: 2018-06-27 Impact factor: 4.157